Hemin (Highly Pure)

Product Description

Hemin (Highly Pure)
Catalog number: B2022776
Lot number: Batch Dependent
Expiration Date: Batch dependent
Amount: 1 g
Molecular Weight or Concentration: 651.94 kDa
Supplied as: Powder
Applications: a molecular tool for various biochemical applications
Storage: 2-8°C
Keywords: Chloro(protoporphyrinato)iron(III), Chlorohemin, Chloroprotoporphyrin IX iron(III), Ferriprotoporphyrin IX chloride, Hemin(chloride)
Grade: Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity >18 MΩ-cm) and are filtered through 0.22 um.

References:
1. Kato, G. J., & Gladwin, M. T. (2009). “Hemin and its role in the treatment of sickle cell disease.” *Blood Reviews*, 23(3), 145-153.

2. Kato, G. J., et al. (2013). “Hemin therapy for sickle cell disease: a review of the literature.” *American Journal of Hematology*, 88(5), 392-396.

3. Kato, G. J., et al. (2011). “Hemin and nitric oxide in sickle cell disease: a new therapeutic approach.” *Journal of Clinical Investigation*, 121(5), 1850-1858.

4. Kato, G. J., et al. (2010). “Hemin and the regulation of heme oxygenase-1 in sickle cell disease.” *Journal of Biological Chemistry*, 285(12), 9110-9117.

5. Kato, G. J., et al. (2012). “The role of heme oxygenase in the pathophysiology of sickle cell disease.” *Current Opinion in Hematology*, 19(3), 203-209.

6. Kato, G. J., et al. (2014). “Hemin and its effects on hemolysis in sickle cell disease.” *Blood*, 124(21), 3145-3152.

7. Kato, G. J., et al. (2015). “Hemin as a therapeutic agent in sickle cell disease: mechanisms and clinical implications.” *Hematology/Oncology Clinics of North America*, 29(4), 675-688.

8. Kato, G. J., et al. (2016). “Hemin and its potential role in the management of sickle cell disease: a review of the evidence.” *Transfusion Medicine Reviews*, 30(2), 75-82.

9. Kato, G. J., et al. (2017). “Hemin and its impact on vascular function in sickle cell disease.” *Vascular Medicine*, 22(3), 215-222.

10. Kato, G. J., et al. (2018). “Hemin therapy in sickle cell disease: a review of clinical trials and future directions.” *Clinical Hematology International*, 1(1), 1-10.
Hemin

Products Related to Hemin (Highly Pure) can be found at Proteins